BiVictriX Therapeutics Plc – LSE:BVX.L
BiVictriX Therapeutics stock price today
BiVictriX Therapeutics stock price monthly change
BiVictriX Therapeutics stock price quarterly change
BiVictriX Therapeutics stock price yearly change
BiVictriX Therapeutics key metrics
Market Cap | 8.25M |
Enterprise value | N/A |
P/E | N/A |
EV/Sales | N/A |
EV/EBITDA | N/A |
Price/Sales | N/A |
Price/Book | N/A |
PEG ratio | N/A |
EPS | -0.07 |
Revenue | N/A |
EBITDA | -5.68M |
Income | -5.04M |
Revenue Q/Q | N/A |
Revenue Y/Y | N/A |
Profit margin | 0% |
Oper. margin | 0% |
Gross margin | 0% |
EBIT margin | 0% |
EBITDA margin | N/A |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeBiVictriX Therapeutics stock price history
BiVictriX Therapeutics stock forecast
BiVictriX Therapeutics financial statements
| Jun 2022 | 0 | -1.34M | |
|---|---|---|---|
| Dec 2022 | 0 | -1.15M | |
| Jun 2023 | 0 | -1.17M | |
| Dec 2023 | 0 | -1.37M |
| 2025 | 10M | 3.18M | 31.89% |
|---|---|---|---|
| 2026 | 25M | 19.02M | 76.1% |
Analysts Price target
Financials & Ratios estimates
| Jun 2022 | 5751000 | 700K | 12.17% |
|---|---|---|---|
| Dec 2022 | 4536000 | 579K | 12.76% |
| Jun 2023 | 3457000 | 625K | 18.08% |
| Dec 2023 | 4295000 | 758K | 17.65% |
| Jun 2022 | -1.32M | -194K | 0 |
|---|---|---|---|
| Dec 2022 | -1.07M | -185K | 0 |
| Jun 2023 | -1.22M | -160K | 0 |
| Dec 2023 | -715K | 155K | 1.93M |
BiVictriX Therapeutics alternative data
| Aug 2023 | 17 |
|---|---|
| Sep 2023 | 17 |
| Oct 2023 | 17 |
| Nov 2023 | 17 |
| Dec 2023 | 17 |
| Jan 2024 | 17 |
| Feb 2024 | 17 |
| Mar 2024 | 17 |
| Apr 2024 | 17 |
| May 2024 | 17 |
| Jun 2024 | 17 |
| Jul 2024 | 17 |
BiVictriX Therapeutics other data
-
What's the price of BiVictriX Therapeutics stock today?
One share of BiVictriX Therapeutics stock can currently be purchased for approximately $29.5.
-
When is BiVictriX Therapeutics's next earnings date?
Unfortunately, BiVictriX Therapeutics's (BVX.L) next earnings date is currently unknown.
-
Does BiVictriX Therapeutics pay dividends?
No, BiVictriX Therapeutics does not pay dividends.
-
How much money does BiVictriX Therapeutics make?
BiVictriX Therapeutics has a market capitalization of 8.25M.
-
What is BiVictriX Therapeutics's stock symbol?
BiVictriX Therapeutics Plc is traded on the LSE under the ticker symbol "BVX.L".
-
What is BiVictriX Therapeutics's primary industry?
Company operates in the Healthcare sector and Biotechnology industry.
-
How do i buy shares of BiVictriX Therapeutics?
Shares of BiVictriX Therapeutics can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
How many employees does BiVictriX Therapeutics have?
As Jul 2024, BiVictriX Therapeutics employs 17 workers.
-
When BiVictriX Therapeutics went public?
BiVictriX Therapeutics Plc is publicly traded company for more then 4 years since IPO on 11 Aug 2021.
-
What is BiVictriX Therapeutics's official website?
The official website for BiVictriX Therapeutics is bivictrix.com.
BiVictriX Therapeutics company profile:
BiVictriX Therapeutics Plc
bivictrix.comLSE
17
Biotechnology
Healthcare
BiVictriX Therapeutics Plc, a biotechnology company, engages in the development of cancer therapies in the United Kingdom. The company develops Bi-Cygni therapeutics, which are selective for cancer types. Its lead program is BVX001, focuses on acute myeloid leukaemia. The company was formerly known as BiVictriX Plc and changed its name to BiVictriX Therapeutics Plc in August 2021. BiVictriX Therapeutics Plc was founded in 2016 and is headquartered in Macclesfield, the United Kingdom.
Macclesfield, SK10 4TG
:
ISIN: GB00BNXH3K91
:
